Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”

After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article, we describe the choices made in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruhn, Hanne, Anderson, Annie S., Hickman, Amy, Macaskill, E. Jane, Treweek, Shaun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179700/
https://www.ncbi.nlm.nih.gov/pubmed/34090495
http://dx.doi.org/10.1186/s13063-021-05340-3
_version_ 1783703842297217024
author Bruhn, Hanne
Anderson, Annie S.
Hickman, Amy
Macaskill, E. Jane
Treweek, Shaun
author_facet Bruhn, Hanne
Anderson, Annie S.
Hickman, Amy
Macaskill, E. Jane
Treweek, Shaun
author_sort Bruhn, Hanne
collection PubMed
description After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article, we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic, and we hope this article can help other trial teams to plan their own online events. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05340-3.
format Online
Article
Text
id pubmed-8179700
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81797002021-06-07 Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial” Bruhn, Hanne Anderson, Annie S. Hickman, Amy Macaskill, E. Jane Treweek, Shaun Trials Letter After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article, we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic, and we hope this article can help other trial teams to plan their own online events. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05340-3. BioMed Central 2021-06-05 /pmc/articles/PMC8179700/ /pubmed/34090495 http://dx.doi.org/10.1186/s13063-021-05340-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Bruhn, Hanne
Anderson, Annie S.
Hickman, Amy
Macaskill, E. Jane
Treweek, Shaun
Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
title Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
title_full Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
title_fullStr Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
title_full_unstemmed Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
title_short Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
title_sort letter on “sharing trial results directly with trial participants and other stakeholders after the sars-cov-2 pandemic hit the uk – experience from the actwell trial”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179700/
https://www.ncbi.nlm.nih.gov/pubmed/34090495
http://dx.doi.org/10.1186/s13063-021-05340-3
work_keys_str_mv AT bruhnhanne letteronsharingtrialresultsdirectlywithtrialparticipantsandotherstakeholdersafterthesarscov2pandemichittheukexperiencefromtheactwelltrial
AT andersonannies letteronsharingtrialresultsdirectlywithtrialparticipantsandotherstakeholdersafterthesarscov2pandemichittheukexperiencefromtheactwelltrial
AT hickmanamy letteronsharingtrialresultsdirectlywithtrialparticipantsandotherstakeholdersafterthesarscov2pandemichittheukexperiencefromtheactwelltrial
AT macaskillejane letteronsharingtrialresultsdirectlywithtrialparticipantsandotherstakeholdersafterthesarscov2pandemichittheukexperiencefromtheactwelltrial
AT treweekshaun letteronsharingtrialresultsdirectlywithtrialparticipantsandotherstakeholdersafterthesarscov2pandemichittheukexperiencefromtheactwelltrial

Ejemplares similares